Last reviewed · How we verify
PVT-1
At a glance
| Generic name | PVT-1 |
|---|---|
| Sponsor | PlusVitech S.L. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer (PHASE2)
- The Role of ctDNA, PVT1 and ROS in Diagnosis and Treatment of Gastrointestinal and Hepatobiliary Pancreatic Cancer
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PVT-1 CI brief — competitive landscape report
- PVT-1 updates RSS · CI watch RSS
- PlusVitech S.L. portfolio CI